Helena Solleiro-Villavicencio

Dr. Helena Solleiro-Villavicencio


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2020 in Environmental Research
Verified
Journal Article
Closed access
DPDiddier Giovanni Prada-Ortega
Diddier Giovanni Prada-Ortega
GLGerard López
Gerard López
HSHelena Solleiro-Villavicencio
Helena Solleiro-Villavicencio
CGClaudia M García-Cuellar
Claudia M García-Cuellar
ABAndrea Baccarelli
Andrea Baccarelli

1 January 2021 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Closed access
DRDaniela Rebolledo-Solleiro
Daniela Rebolledo-Solleiro
LFLaura Y Castillo Flores
Laura Y Castillo Flores
HSHelena Solleiro-Villavicencio
Helena Solleiro-Villavicencio
Bisphenol A (BPA), a compound used in the manufacturing of plastics and epoxy resins, is an endocrine disruptor with significant adverse impact on the human's health. Here, we review the animal models and clinical studies as well as the molecular and cellular mechanisms that show that BPA alters the normal function of the reproductive system, metabolism, brain function and behavior and contributes to the development of certain neurodevelopmental disorders including autism spectrum and attention-deficit and hyperactivity disorders. BPA also causes aberrant cognitive function, behavioral disturbances, and neurodegenerative diseases, including Parkinson's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis. It has recently been proposed that exposure to BPA may be associated with the development of certain neurodegenerative diseases and neurodevelopmental disorders; however, it is a line of research that is just emerging. This work aims to review the available information about the association between exposure to BPA and cognitive function, behavioral disturbances, neurodegenerative diseases (Parkinson´s Disease, Amyotrophic lateral sclerosis, Multiple Sclerosis), and neurodevelopmental disorders (Autism Spectrum and Attention-Deficit/Hyperactivity Disorders). Likewise, the molecular and cellular mechanisms that may be involved with these pathological conditions will be analyzed.

1 December 2015 in Clinical Immunology
Verified
Journal Article
Closed access
HSHelena Solleiro-Villavicencio
Helena Solleiro-Villavicencio
RQRoger Quintana-Carrillo
Roger Quintana-Carrillo
Ramcés Falfán-ValenciaRamcés Falfán-Valencia
Ramcés Falfán-Valencia
MVMaría Inés Vargas-Rojas
María Inés Vargas-Rojas

29 February 2024 in Life
Verified
Journal Article
Open access
PDF file
JGJosé Alfredo de Jesús Aguayo Guerrero
José Alfredo de Jesús Aguayo Guerrero
LMLucia Angelica Mendez
Lucia Angelica Mendez
HSHelena Solleiro-Villavicencio
Helena Solleiro-Villavicencio
RVRebeca Viurcos-Sanabria
Rebeca Viurcos-Sanabria
GEGalileo Escobedo
Galileo Escobedo
Sucralose is a food additive initially used to mitigate glycemic peaks and calorie intake in patients with diabetes and obesity. Although sucralose has been considered safe for human consumption, the World Health Organization (WHO) issued a global alert in 2023 concerning the potential health implications of this artificial sweetener. This review aims to comprehensively explore the effects of sucralose intake on human health by understanding sucralose absorption, metabolism, and excretion. We also outline the role of the sweet taste 1 receptor 3 (T1R3) in mediating sucralose-dependent signaling pathways that regulate satiety, incretin release, and insulin response. Finally, we discuss the impact of sucralose on microbiome dysbiosis, inflammatory response origin, liver damage, and toxicity. Gaining a deeper understanding of the manifold effects of sucralose on human physiology will help promote further studies to ensure its consumption is deemed safe for a broader population, including children, adolescents, and pregnant women.